Target intelligence / Profile preview

E2F transcription factor 6 pseudogene 3 (E2F6P3)

Target: E2F6P3
Molecular classification: Other (pseudogene)

Overview

E2F transcription factor 6 pseudogene 3 (E2F6P3) is a processed pseudogene related to the E2F family of transcription factors, specifically E2F6. Unlike functional E2F family members, which regulate cell cycle, proliferation, and apoptosis, E2F6P3 does not encode a protein and has no known biological function, clinical significance, or therapeutic role. E2F6P3 is distinct from the protein-coding gene E2F6, which is involved in transcriptional regulation and cell cycle control. E2F6P3 should not be considered a druggable or therapeutic target, and its inclusion on a target list is likely due to confusion with the canonical transcription factor gene.

Other names: E2F6P3E2F6 pseudogene 3E2F transcription factor 6 pseudogene 3

Beyond the preview

Go deeper on E2F transcription factor 6 pseudogene 3 (E2F6P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E2F transcription factor 6 pseudogene 3 (E2F6P3).

Explore the full profile